Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preparing for the next viral threat with broad-spectrum antivirals
Marwah Karim, Chieh‐Wen Lo, Shirit Einav
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 24

Showing 24 citing articles:

Mpox (formerly monkeypox): pathogenesis, prevention and treatment
Junjie Lu, Hui Xing, Chunhua Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Phenylboronic Acid-Modified Membrane-Like Magnetic Quantum Dots Enable the Ultrasensitive and Broad-Spectrum Detection of Viruses by Lateral Flow Immunoassay
Chongwen Wang, Qing Yu, Shuai Zheng, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16752-16765
Closed Access | Times Cited: 25
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 29
Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 7
Purine but Not Pyrimidine De Novo Nucleotide Biosynthesis Inhibitors Strongly Enhance the Antiviral Effect of Corresponding Nucleobases Against Dengue Virus
Laurent Bonnac, Christine D. Dreis, Madhu Rai, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 210-210
Open Access
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
DHODH inhibitors: What will it take to get them into the clinic as antivirals?
Anna Luganini, Donatella Boschi, Marco L. Lolli, et al.
Antiviral Research (2025) Vol. 236, pp. 106099-106099
Open Access
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates
Prakash D. Jadhav, Xueying Liang, Ahmadullah Ansari, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1
Maria Orfanoudaki, Lauren R. H. Krumpe, Shilpa R. Shenoy, et al.
Journal of Biological Chemistry (2025), pp. 108319-108319
Open Access
Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2
Blandine Padey, Clément Droillard, Victoria Dulière, et al.
Antiviral Research (2025), pp. 106138-106138
Open Access
Paving new roads toward the advancement of broad‐spectrum antiviral agents
Ruikun Du, Jazmin Galván Achi, Qinghua Cui, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
New Approaches to Etiotropic Therapy of ARVI Patients with Riamilovir
К. В. Жданов, Oleg V. Maltsev, Kristina V. Kasyanenko, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2024) Vol. 68, Iss. 9-10, pp. 63-71
Open Access | Times Cited: 2
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
Marwah Karim, Manjari Mishra, Chieh‐Wen Lo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Commensal bacteria inhibit viral infections via a tryptophan metabolite
Danting Jiang, Nicole Soo, Chin Yee Tan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Antiviral drugs in animal-derived matrices: A review
Samantha Sasse, Ane Arrizabalaga-Larrañaga, Saskia S. Sterk
Heliyon (2024), pp. e37460-e37460
Open Access | Times Cited: 1
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice
Aaron F. Carlin, James R. Beadle, Jeremy Ardanuy, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access | Times Cited: 1
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Antiviral Potential of Azelastine against Major Respiratory Viruses
Katrin Fischhuber, Zoltán Bánki, Janine Kimpel, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2300-2300
Open Access | Times Cited: 3
Novel derivatives of BCV and (S)-HPMPA inhibit orthopoxviruses and human adenoviruses more potently than BCV
Yifan Zhang, Yanmin Wan, Cuiyuan Guo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Novel Derivatives of BCV and (S)-HPMPA Inhibit Orthopoxviruses and Human Adenoviruses More Potently Than BCV
Yifan Zhang, Yanmin Wan, Cuiyuan Guo, et al.
(2024)
Open Access
Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activity
P. R. Nitha, Wouter Van den Eynde, Marwah Karim, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116967-116967
Closed Access
Novel Derivatives of BCV and (S)-HPMPA Inhibit Orthopoxviruses and Human Adenoviruses More Potently Than BCV
Yifan Zhang, Yanmin Wan, Cuiyuan Guo, et al.
(2024)
Open Access
Host-Directed Repurposed Diltiazem Enhances the Antiviral Activity of Classic Antivirals Against Influenza and Sars-Cov-2
Blandine Padey, Clément Droillard, Victoria Dulière, et al.
(2024)
Closed Access
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations
Jiqian Xu, Wanying Zhang, Jiaji Fu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access
Page 1

Scroll to top